Molecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory Infections
Summary
WOBURN, Mass., Dec. 13, 2023 /PRNewswire/ -- Molecular Loop Biosciences, Inc., an innovator at the forefront of targeted sequencing technologies, is pleased to announce that it has received a $1.8 million grant from the Bill & Melinda Gates Foundation to further its groundbreaking work in the field of multi-pathogen genomics. The grant will support a project to expand access to next-generation sequencing (NGS) for the surveillance of infectious disease pathogens in low- and middle-income countries (LMICs). LoopCap addresses challenges in sample turn-around time and dropouts due to rapid mutation both common issues with pathogen sequencing methods today," said Greg Porreca, PhD, CEO of Molecular Loop. Molecular Loop will utilize this grant to develop and evaluate a multiplex NGS assay for the genomic analysis of the causative agents of respiratory infections. The company leverages its technology and deep genomic expertise to accelerate innovations in life sciences and make advancements in personalized healthcare.